AKT1 and myocardial infarction: Evidence revealed that metformin significantly increased phosphorylation of Akt (also known as PKB), thereby inhibiting the opening of mPTP, and it activated the downstream kinase of the reperfusion-induced survival kinase (RISK), thereby alleviating myocardial infarction [72, 73].